title: Decitabine improves outcomes in older patients with acute myeloid leukemia and higher blast counts.
authors: Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas.
authors: Tapan M
authors: TM
authors: Kadia
authors: Department of Haematology, Lyon-Sud Hospital, Lyon, France.
authors: Xavier G
authors: XG
authors: Thomas
authors: Department of Hematooncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland.
authors: Anna
authors: A
authors: Dmoszynska
authors: Department of Hematology, Medical University of Lodz, Lodz, Poland.
authors: Agnieszka
authors: A
authors: Wierzbowska
authors: Princess Margaret Cancer Center, Toronto, Canada.
authors: Mark
authors: M
authors: Minden
authors: Department of Haematology, Royal North Shore Hospital, St. Leonards, New South Wales, Australia.
authors: Christopher
authors: C
authors: Arthur
authors: Nantes University Hospital, Nantes, France.
authors: Jacques
authors: J
authors: Delaunay
authors: Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas.
authors: Farhad
authors: F
authors: Ravandi
authors: Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas.
authors: Hagop
authors: H
authors: Kantarjian
mesh_terms: D000367:Age Factors; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D001374:Azacitidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D001853:Bone Marrow / Q000187:drug effects / Q000473:pathology; D000077209:Decitabine; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D008297:Male; D008875:Middle Aged; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D000964:Antimetabolites, Antineoplastic; D000077209:Decitabine; D001374:Azacitidine